Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Gildan
GIL
$10.6B
| $285K | ﹤0.01% |
7,505
-21,136
| -74% | -$764K |
|
3252
American Express Global Business Travel
GBTG
$4.94B
| $284K | ﹤0.01% |
42,977
+20,208
| +89% | +$124K |
|
|
CRGX
3253
DELISTED
CARGO Therapeutics
CRGX
| $283K | ﹤0.01% |
17,252
-3,306
| -16% | -$62.9K |
|
3254
Vicor
VICR
$10.2B
| $283K | ﹤0.01% |
8,534
-11,589
| -58% | -$400K |
|
3255
Simulations Plus
SLP
$371M
| $282K | ﹤0.01% |
5,804
-8,545
| -60% | -$403K |
|
|
ETWO
3256
DELISTED
E2open Parent Holdings
ETWO
| $281K | ﹤0.01% |
62,657
-91,421
| -59% | -$412K |
|
3257
Neumora Therapeutics
NMRA
$302M
| $280K | ﹤0.01% |
28,532
+18,110
| +174% | +$187K |
|
|
DX
3258
Dynex Capital
DX
$3.21B
| $280K | ﹤0.01% |
23,453
-73,563
| -76% | -$884K |
|
3259
AngioDynamics
ANGO
$649M
| $279K | ﹤0.01% |
46,188
-16,314
| -26% | -$101K |
|
3260
Annexon
ANNX
$886M
| $279K | ﹤0.01% |
56,976
-17,924
| -24% | -$92.7K |
|
3261
Matthews International
MATW
$739M
| $278K | ﹤0.01% |
11,112
-15,484
| -58% | -$425K |
|
|
PPLI
3262
People Inc
PPLI
$3.1B
| $278K | ﹤0.01% |
7,241
-15,997
| -69% | -$661K |
|
|
CTO
3263
CTO Realty Growth
CTO
$815M
| $278K | ﹤0.01% |
15,925
-2,009
| -11% | -$34.8K |
|
3264
Matrix Service
MTRX
$335M
| $278K | ﹤0.01% |
28,001
-57,404
| -67% | -$656K |
|
3265
Nokia
NOK
$52.3B
| $278K | ﹤0.01% |
73,545
+61,149
| +493% | +$226K |
|
3266
Ivanhoe Electric
IE
$1.74B
| $278K | ﹤0.01% |
29,615
-29,565
| -50% | -$314K |
|
3267
Castle Biosciences
CSTL
$979M
| $277K | ﹤0.01% |
12,734
-34,691
| -73% | -$773K |
|
3268
Evolus
EOLS
$501M
| $276K | ﹤0.01% |
25,449
-17,138
| -40% | -$211K |
|
3269
Savara
SVRA
$1.19B
| $274K | ﹤0.01% |
67,961
-10,110
| -13% | -$45K |
|
3270
Bally's
BALY
$658M
| $274K | ﹤0.01% |
22,852
-19,041
| -45% | -$243K |
|
|
PLGO
3271
Pelagos Insurance Capital
PLGO
$2.14B
| $273K | ﹤0.01% |
16,765
-25,764
| -61% | -$456K |
|
3272
Harrow
HROW
$1.51B
| $273K | ﹤0.01% |
13,087
-31,311
| -71% | -$468K |
|
|
LONA
3273
LeonaBio Inc
LONA
$72.1M
| $273K | ﹤0.01% |
10,307
-2,860
| -22% | -$67.4K |
|
3274
Pagaya Technologies
PGY
$1.78B
| $272K | ﹤0.01% |
21,304
-67,771
| -76% | -$761K |
|
|
NOA
3275
North American Construction
NOA
$395M
| $272K | ﹤0.01% |
14,093
-3,642
| -21% | -$75.8K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.